Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results
Standard BioTools Completes Sale of SomaLogic to Illumina
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
Standard BioTools Reports Third Quarter 2025 Financial Results
Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025
Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.